Skip to main content
. 2020 Dec 15;8:579536. doi: 10.3389/fbioe.2020.579536

Figure 2.

Figure 2

Advantages of nanoliposomes based formulations respect to non-nanoliposomes based formulations for oral, topical, and intramuscular drug administration.